#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4234621	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta2gamma3 expressed in Escherichia coli BL21 cells using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
2.	ALA4234630	B	Binding affinity to Bap-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells by SPR analysis	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
3.	ALA4234631	B	Binding affinity to Bap-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells assessed as dissociation rate constant by SPR analysis	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
4.	ALA4234632	B	Binding affinity to Bap-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells assessed as association rate constant by SPR analysis	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
5.	ALA4234633	B	Binding affinity to Bap-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells assessed as dissociation half life by SPR analysis	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
6.	ALA4234634	A	Apparent passive permeability of the compound in RRCK cells by FACS analysis	Canis lupus familiaris	6	ALA4229467	cell-based format	Scientific Literature
7.	ALA4234635	P	Lipophilicity, log D of the compound at pH 7.4 at 0.52 mg after 1 hr by shake-flask method		6	ALA4229467	small-molecule physicochemical format	Scientific Literature
8.	ALA4234636	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta2gamma3 expressed in Escherichia coli BL21 cells at 1 nM using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay relative to AMP control	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
9.	ALA4234637	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta2gamma1 expressed in Escherichia coli BL21 cells at 1 nM using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay relative to AMP control	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
10.	ALA4234638	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha1beta2gamma1 expressed in Escherichia coli BL21 cells at 0.5 nM using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay relative to AMP control	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
11.	ALA4234639	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta1gamma1 expressed in Escherichia coli BL21 cells at 2 nM using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay relative to AMP control	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
12.	ALA4234640	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells at 0.25 nM using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay relative to AMP control	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
13.	ALA4234641	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta2gamma1 expressed in Escherichia coli BL21 cells using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
14.	ALA4234642	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha1beta2gamma1 expressed in Escherichia coli BL21 cells using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
15.	ALA4234643	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha2beta1gamma1 expressed in Escherichia coli BL21 cells using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
16.	ALA4234644	B	Activation of full-length recombinant N-terminal His-tagged human AMPKalpha1beta1gamma1 expressed in Escherichia coli BL21 cells using Cy-5 SAMS peptide as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins in presence of PP2a by TR-FRET assay	Homo sapiens	6	ALA4229467	cell-based format	Scientific Literature
17.	ALA4234645	P	Half life of the compound in deuteriated phosphate buffer at pH 7.4 at 37 degC measured every 25 mins for 21 hrs by 1H NMR analysis		3	ALA4229467	small-molecule physicochemical format	Scientific Literature
18.	ALA4234646	A	Retention time of the compound in human hepatocytes at 10 uM after 4 hrs by HPLC-UV analysis	Homo sapiens	7	ALA4229467	cell-based format	Scientific Literature
19.	ALA4234648	A	Drug level in human hepatocytes treated with (S)-4,6-difluoro-5-(4-(tetrahydro-2H-pyran-2-yl)phenyl)-1H-indole-3-carboxylic acid at 10 uM after 4 hrs by HPLC-UV analysis	Homo sapiens	1	ALA4229467	cell-based format	Scientific Literature